Health care startups in Denmark
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Corti | Copenhagen | Series B | $59.6M | 2023-09-20 |
| ADCendo | Copenhagen | Series C | $75.0M | 2026-04-14 |
| Teton | Copenhagen | Series A | $20.0M | 2025-09-09 |
| Octarine Bio | Copenhagen | Series A | $5.9M | 2026-01-22 |
| Invert | Copenhagen | Seed | $20.1M | 2024-07-10 |
| NMD Pharma | Risskov | Series B | $81.4M | 2023-11-15 |
| Famly | Copenhagen | Series A | $18.0M | 2021-12-14 |
| Alcolase | Copenhagen | Seed | $1.7M | 2026-05-18 |
8 rows of the CSV in 5 of its 18 columns.
- The 131 health care startups in Denmark have raised $1.9B in total.
- 23 of them closed their most recent round in the last 12 months, $331.5M combined.
- The largest of those rounds is Sidera Bio's $109.0M Series A, dated December 2025.
- The most recent is Breye Therapeutics' $76.7M Series A on 29 September 2026.
- Export and Investment Fund is an investor in 6 of them, more than any other fund.
- Biotech is the most common other sector, with 58 companies (44%).
- 44% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 1 to 10 employees (55% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
17 of 131| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Alcolase | Alcolase is a Danish life science start-up developing treatments for alcohol flushing. | Biotech | Copenhagen | Seed | $1.7M | 2026-05-18 | $2.6M | Antler | 1 to 10 | 2021 |
| ADCendo | ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. | Biotech | Copenhagen | Series C | $75.0M | 2026-04-14 | $324.6M | RA Capital Management, Novo Holdings, Gilde Healthcare +2 | 51 to 100 | 2017 |
| Biomia | Biomia develops plant-derived natural products for unmet medical needs using synthetic biology. | Biotech | Lyngby | Seed | $3.0M | 2026-02-09 | $3.0M | BlueYard Capital, Amino Collective, Nucleus Capital | 1 to 10 | 2022 |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. | Biotech | Copenhagen | Series A | $5.9M | 2026-01-22 | $15.5M | MassChallenge, Vaekstfonden, Unconventional Ventures +2 | 11 to 50 | 2018 |
| HHC Medical | HHC Medical develops targeted non-invasive drug delivery devices. | Health care | Hillerød | Pre-seed | $194K | 2025-12-12 | $3.3M | Export and Investment Fund, Innovation Fund Denmark | 1 to 10 | 2019 |
| Teton | Teton is building an AI nurse companion. | Artificial intelligence | Copenhagen | Series A | $20.0M | 2025-09-09 | $25.9M | PSV, Plural Platform, Nebular | 11 to 50 | 2020 |
| SNIPR Biome | SNIPR Biome develops discovery-stage biotech treatments for microbial diseases. | Biotech | Copenhagen | Series B | $40.9M | 2025-08-07 | $103.4M | Wellington Partners, Bill & Melinda Gates Foundation, EQT Life Sciences +1 | 11 to 50 | 2017 |
| Droplet IV | Droplet IV develops automated technology for intravenous infusion therapy to reduce nursing workload. | Biotech | Kongens Lyngby | Seed | $2.0M | 2025-06-17 | $4.0M | MedTech Innovator, BioInnovation Institute Venture Lab, BioInnovation Institute Venture House | 1 to 10 | 2022 |
| MedTrace Pharma | MedTrace Pharma helps doctors diagnose critically ill patients faster and more accurately. | Biotech | Lyngby | Series F | $11.1M | 2025-05-12 | $63.4M | European Innovation Council, Vaekstfonden, ATP +1 | 11 to 50 | 2015 |
| Commit Biologics | Commit Biologics develops a novel immunotherapy platform for treating cancer. | Biotech | Aarhus | Seed | $5.7M | 2025-01-28 | $23.7M | Novo Holdings, Innovation Fund Denmark, Bioqube Ventures | 11 to 50 | 2021 |
| Kin, Personal AI | Kin, Personal AI is a personal AI coach that supports people in their work lives. | Artificial intelligence | Copenhagen | Seed | $2.8M | 2024-12-12 | Accelerace, Seier Capital, Morph Capital +2 | 11 to 50 | 2022 | |
| Invert | Invert provides AI-driven software that supports real-time decisions in bioprocessing. | Artificial intelligence | Copenhagen | Seed | $20.1M | 2024-07-10 | $20.6M | Y Combinator, Giant Ventures | 11 to 50 | 2021 |
| Hoba Therapeutics | Hoba Therapeutics develops a new therapeutic protein for treating neuropathic pain. | Biotech | Copenhagen | Series A | $24.8M | 2023-12-11 | European Innovation Council, EIC Accelerator, Novo Holdings +2 | 1 to 10 | 2016 | |
| NMD Pharma | NMD Pharma discovers small molecule drugs for neuromuscular disorders. | Health care | Risskov | Series B | $81.4M | 2023-11-15 | $171.5M | Novo Holdings, Inkef, Jeito Capital +2 | 11 to 50 | 1986 |
| Corti | Corti is an AI company that offers healthcare software for patient consultations and clinical workflows. | Artificial intelligence | Copenhagen | Series B | $59.6M | 2023-09-20 | Eurazeo, Heartcore Capital, Export and Investment Fund +1 | 101 to 250 | 2016 | |
| Famly | Famly is an early childhood platform that connects parents and staff who care for young children. | Education | Copenhagen | Series A | $18.0M | 2021-12-14 | $22.1M | Susquehanna Growth Equity, True Growth Capital | 101 to 250 | 2013 |
| Lenus eHealth | Lenus eHealth provides cloud-based SaaS to a wide range of health professionals. | Health care | Copenhagen | Series A | $63.3M | 2021-06-08 | $63.3M | EQT Ventures | 251 to 500 | 2016 |
Table 1. Health care startups in Denmark: the 17 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 131.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ADCendo | ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. | Biotech | Copenhagen | Series C | $75.0M | 2026-04-14 | $324.6M | RA Capital Management, Novo Holdings, Gilde Healthcare +2 | 51 to 100 | 2017 |
| 2 | Octarine Bio | Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. | Biotech | Copenhagen | Series A | $5.9M | 2026-01-22 | $15.5M | MassChallenge, Vaekstfonden, Unconventional Ventures +2 | 11 to 50 | 2018 |
| 3 | Biomia | Biomia develops plant-derived natural products for unmet medical needs using synthetic biology. | Biotech | Lyngby | Seed | $3.0M | 2026-02-09 | $3.0M | BlueYard Capital, Amino Collective, Nucleus Capital | 1 to 10 | 2022 |
| 4 | Alcolase | Alcolase is a Danish life science start-up developing treatments for alcohol flushing. | Biotech | Copenhagen | Seed | $1.7M | 2026-05-18 | $2.6M | Antler | 1 to 10 | 2021 |
| 5 | HHC Medical | HHC Medical develops targeted non-invasive drug delivery devices. | Health care | Hillerød | Pre-seed | $194K | 2025-12-12 | $3.3M | Export and Investment Fund, Innovation Fund Denmark | 1 to 10 | 2019 |
Table 2. Health care startups in Denmark: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Export and Investment Fund | Government investment office | Hellerup, Denmark | 6 | 5% | 1 | HHC Medical |
| 2 | Novo Holdings | Corporate venture arm | Hellerup, Denmark | 6 | 5% | 1 | ADCendo |
| 3 | PSV | Venture capital firm | Lyngby, Denmark | 4 | 3% | ||
| 4 | Vaekstfonden | Venture capital firm | Hellerup, Denmark | 4 | 3% | 1 | Octarine Bio |
| 5 | Innovation Fund Denmark | Government investment office | Copenhagen, Denmark | 4 | 3% | 1 | HHC Medical |
| 6 | Accelerace | Startup accelerator | Copenhagen, Denmark | 3 | 2% | ||
| 7 | European Innovation Council | Startup accelerator | Brussels, Belgium | 3 | 2% | ||
| 8 | Inkef | Venture capital firm | Amsterdam, The Netherlands | 2 | 2% | ||
| 9 | Antler | Venture capital firm | Singapore | 2 | 2% | 1 | Alcolase |
| 10 | Prosus Ventures | Corporate venture arm | Amsterdam, The Netherlands | 1 | 1% | ||
| 11 | Heartcore Capital | Venture capital firm | Copenhagen, Denmark | 1 | 1% | ||
| 12 | Eurazeo | Private equity firm | Paris, France | 1 | 1% | ||
| 13 | Gilde Healthcare | Private equity firm | Utrecht, The Netherlands | 1 | 1% | 1 | ADCendo |
| 14 | RA Capital Management | Startup incubator | Boston, United States | 1 | 1% | 1 | ADCendo |
| 15 | Pontifax | Venture capital firm | Herzliya, Israel | 1 | 1% | 1 | ADCendo |
Table 3. Health care startups in Denmark: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups in Denmark by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Denmark by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Copenhagen | 69 | 53% |
| Aarhus | 15 | 11% |
| Frederiksberg | 5 | 4% |
| Kongens Lyngby | 5 | 4% |
| Lyngby | 4 | 3% |
| Odense | 4 | 3% |
| Hørsholm | 3 | 2% |
| Københoved | 3 | 2% |
| Aalborg | 3 | 2% |
| Risskov | 2 | 2% |
| Horsens | 2 | 2% |
| Vejle | 2 | 2% |
Table 6. Health care startups in Denmark by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 6 | 26% | $81.7M |
| August 2026 | 1 | 4% | |
| May 2026 | 2 | 9% | $1.7M |
| April 2026 | 1 | 4% | $75.0M |
| March 2026 | 3 | 13% | $4.6M |
| February 2026 | 4 | 17% | $12.4M |
| January 2026 | 3 | 13% | $41.0M |
| December 2025 | 3 | 13% | $115.1M |
Table 7. Health care startups in Denmark: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 20 | 15% | $216.4M |
| 2025 | 21 | 16% | $411.2M |
| 2024 | 16 | 12% | $170.3M |
| 2023 | 17 | 13% | $283.9M |
| 2022 | 14 | 11% | $49.1M |
| 2021 | 9 | 7% | $96.0M |
Table 8. Health care startups in Denmark by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 24 | 18% |
| 2020 to 2022 | 33 | 25% |
| 2015 to 2019 | 50 | 38% |
| 2010 to 2014 | 16 | 12% |
| Before 2010 | 8 | 6% |
Table 9. Health care startups in Denmark by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 71 | 55% |
| 11 to 50 | 48 | 38% |
| 51 to 100 | 6 | 5% |
| 101 to 250 | 2 | 2% |
| 251 to 500 | 1 | 1% |
Table 10. Health care startups in Denmark by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Denmark. On 16 November 2026 that is 131 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 17 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 131 rows: 36 have no round amount, 0 no city and 47 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Denmark are on the list?
- 131, in the file dated 16 November 2026. 23 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 131 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.